Analyses of Chronic Efficacy Studies with GSM 776890 for Submission of Pre-IND Brochure to FDA Prior to Pre-IND Meeting and IND Filing for SAD/MAD Phase I Safety/Toxicity and for Phase II and III Efficacy Clinical Trials to Support the NDA

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator
Wagner, Steve
Awardee State
Contact PI Country
Project Detail
FY Overall Cost
$259,366
Funding Organization
Agency/Funding Organization
Funding Organization Country